Saiyin Hexige, Na Ning, Han Xu, Fang Yuan, Wu Yanhua, Lou Wenhui, Yang Xianmei
State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200433, People's Republic of China.
Department of Kidney Transplantation, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, People's Republic of China.
Oncotarget. 2017 Jul 4;8(27):44669-44681. doi: 10.18632/oncotarget.17965.
Neoplastic cells in pancreatic ductual adenocarcinoma (PDAC) survive in an energy-deprived milieu, and hyper-activation of Akt is thought to contribute to the neoplastic cell survival in PDAC. Kras activating mutations, common in PDAC, was believed to be the major driver of Akt activation. However, the inhibitor to Kras was not therapeutic for PDAC patients. This implied that PDAC cells might harbor an intrinsic merit that strengthens Akt activity. Here we showed that BRSK2, a serine/threonine-protein kinase of AMPK family, was induced by nutrient deprivation in PDAC cells and suppressed mTORC1 activity via phosphorylation of tuberous sclerosis complex 2 (TSC2). The suppression of mTORC1 activity in PDAC results in a dominant loss of feedback inhibition on Akt activity by mTORC1, consequently enhancing cell survival. This finding indicates that the intrinsic molecular merit that BRSK2 provides is a survival advantage to PDAC cells and strengthens the invasiveness of these neoplastic cells in energy-deprived environments.
胰腺导管腺癌(PDAC)中的肿瘤细胞在能量匮乏的环境中存活,Akt的过度激活被认为有助于PDAC中肿瘤细胞的存活。Kras激活突变在PDAC中很常见,被认为是Akt激活的主要驱动因素。然而,Kras抑制剂对PDAC患者并无治疗效果。这意味着PDAC细胞可能具有增强Akt活性的内在特性。在此我们表明,BRSK2是AMPK家族的一种丝氨酸/苏氨酸蛋白激酶,在PDAC细胞中由营养剥夺诱导产生,并通过磷酸化结节性硬化复合物2(TSC2)来抑制mTORC1活性。PDAC中mTORC1活性的抑制导致mTORC1对Akt活性的反馈抑制作用显著丧失,从而提高细胞存活率。这一发现表明,BRSK2提供的内在分子特性是PDAC细胞的生存优势,并增强了这些肿瘤细胞在能量匮乏环境中的侵袭性。